On Tuesday, the Food and Drug Administration approved additional doses of Pfizer and Moderna’s bivalent Covid-19 vaccine boosters for people 65 and older with weakened immunities. The bivalent booster vaccines reportedly counteract the original Covid-19 strain as well as its spinoffs, like Omicron.